Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net (Loss)	$ (1,142,706)	$ (964,264)
Adjustments to Reconcile net (loss) to Net Cash Used In Operating Activities:
Stock for services and compensation	0	10,200
Amortization expense	1,012	1,012
Amortization of debt discount	8,775	0
Loss on settlement of debt	60,938	875
Stock issued for litigation settlement	462,500	0
Changes in assets and liabilities:
Inventory	1,132
Prepaid and other current assets	7,684	0
Accounts payable and accrued expenses	28,643	191,052
Accrued liabilities - related party	123,881	135,409
Accrued litigation settlement	(100,000)	430,000
Net Cash Used In Operating Activities	(548,141)	(195,716)
Cash Flows from Investing Activities:
Purchase of intangible assets	0	(40,500)
Net Cash Used in Investing Activities	0	(40,500)
Cash Flows from Financing Activities:
Proceeds from related party	0	185,000
Repayments on loan payable	(9,136)	(14,920)
Proceeds from sale of common stock	575,855	77,292
Cash flow provided by financing activities	566,719	247,372
Increase in Cash and Cash Equivalents	18,578	11,156
Cash and Cash Equivalents - Beginning of period	13,377	21,799
CASH AND CASH EQUIVALENTS - END OF PERIOD	31,955	32,955
Supplemental cash flow information:
Cash paid for interest	15	80
Cash paid for income taxes	0	0
Non-cash Investing & Financing Activities:
Common stock issued to settle accrued liabilities - related party	127,500	0
Common stock issued for subscription receivable	71,717	0
Common stock issued to settle accrued liabilities	60,000	3,126
Accrued litigation settlement paid with loan payable	0	100,000
Amortization of deferred offering costs	55,371	0
Accounts payable and accrued expenses paid with promissory note payable	$ 10,000	$ 0